CSL in development of blood-derived Covid-19 treatment

Biotechnology giant CSL has begun development of a blood-derived treatment for Covid-19, known as COVID-19 Immunoglobulin. The Melbourne company believes the product could be used to treat people seriously ill with the complications caused by the virus, particularly those whose illness is progressing towards the need for ventilation. The treatment will be derived from blood…

Circuitwise joins Australian Covid ventilator team

Circuitwise has joined a consortium of innovative local businesses to manufacture emergency ventilators being developed as part of Australia’s response to the Covid-19 pandemic. The contract is to manufacture printed circuit board (PCB) assemblies at its Bella Vista, Sydney factory (pictured) to control 2,000 ventilators being developed by a consortium of companies led by Grey…

Archer in quantum deal with IBM

New materials technology developer Archer Materials has signed an agreement with computing giant IBM to advance their quantum computing ambitions. The company, which is progressing development of a quantum computing chip, has joined the global IBM Q Network as an ‘ecosystem partner’. Archer’s chip, known as the CQ qubit processor, will now utilise IBM’s open…

BAE Systems Australia to work on Boeing Loyal Wingman jet

BAE Systems has been selected to provide key components of the Loyal Wingman unmanned jet aircraft being developed by Boeing Defence Australia and the Royal Australian Air Force (RAAF). Adelaide-based BAE will supply the unmanned flight vehicle management technology, simulation capabilities, flight control computers and navigation equipment for the aircraft. BAE has considerable experience in…